The participation of cardiac myosin hinge in contractility was investigated by in vitro motility and ATPase assays and by measurements of sarcomere shortening. The effect on contractile activity was analyzed using an antibody directed against a 20-amino acid peptide within the hinge region of myosin. This antibody bound specifically at the hinge at a distance of 55 nm from the S1/S2 junction, was specific to human, dog, and rat cardiac myosins, did not crossreact with gizzard or skeletal myosin, and had no effect on ATPase activity of purified S1 and myofibrils. However, it completely suppressed the movement of actin filaments in in vitro motility assays and reduced active shortening of sarcomeres of skinned cardiac myocytes by half. Suppression of motion by the antihinge antibody may reflect a mechanical constraint imposed by the antibody upon the mobility of the S2 region of myosin. The results suggest that the steps in the mechanochemical energy transduction can be separately influenced through S2.
The mechanism of muscle shortening is thought to occur by means of binding of a myosin head (S1) to actin followed by its power stroke and dissociation. The portions of myosin governing the power stroke have been the subject of many studies. Motility assays have shown that the myosin head alone (S1 or heavy meromyosin) is sufficient to move fluorescently labeled actin filaments (1, 2) or move on Nitella actin (3) and, more significantly, that S1 alone is sufficient to generate force in an in vitro system (4) .
It has been proposed that the proteolytically sensitive area within the myosin tail or the hinge region between S2 and light meromyosin may also play a significant role in contraction, possibly by undergoing a helix-to-coil transition following "melting" of the S2 coiled-coil helix. This was deduced from conformational changes within S2 as observed by biochemical (5) (6) (7) (8) and electron microscopic analysis (9) . In support of this hypothesis, a polyclonal anti-S2 antibody was shown to depress tension or isometric force generation in maximally activated glycerinated muscle fibers (10, 11) and to reduce the extent of shortening in isolated myofibrils (11) .
We investigated the influence of S2 on active shortening and motion using an antibody directed against a peptide 20 amino acids long that is totally within the hinge region. Control of crossbridge cycling by myosin occurs physiologically in the heart, and so we selected cardiac myosin and myocytes to test the relevance of the hinge in contractility.
We show that the hinge exerts a pronounced long-range effect that impairs contractile motion without preventing crossbridge attachment under conditions where little tension transmission by S2 occurs. This finding raises a larger question, as to how information about the status of the hinge is physically communicated along S2 and how it is transduced by S1 to affect its interaction with actin. A preliminary report of these observations was presented earlier (12) .
MATERIALS AND METHODS
Preparation ofMyosin and the Hinge Peptide. Human or dog cardiac and turkey gizzard myosins were prepared according to procedures described elsewhere (13, 14) . A 20-amino acid peptide within the hinge was selected from published sequences based on cDNA data identical for a-and 3-myosin heavy chains (15) . The sequence ofamino acids in the peptide (synthesized by Applied Biosystems) was Glu-Arg-Leu-GluGlu-Ala-Gly-Gly-Ala-Thr-Ser-Val-Gln-Ile-Glu-Met-AsnLys-Lys-Arg. This sequence spans residues starting at Glu-711 and terminating at Arg-730 (15) or Glu-1150 to Arg-1169 (16) and is completely within the hinge region.
Preparation of Anti-Hinge Peptide Antibody. The hinge peptide was crosslinked to bovine serum albumin according to Walter et al. (17) , and the resulting bovine serum albuminpeptide antigen complex was used to immunize rabbits as described (18) . The antibody produced was first purified on a DEAE column followed by chromatography on a Sepharose-hinge peptide affinity column (19) . Affinity-and DEAEpurified antibodies were used as indicated in the experiments described below.
Radioimmunoassay (RIA) and Inhibition Experiments. Pure hinge peptide and six different myosins (normal and myopathic human cardiac, turkey gizzard, rabbit skeletal, and dog and rat cardiac) were tested for reactivity versus a double-antibody RIA using rabbit polyclonal affinity-purified anti-hinge IgG, competing with 1251-labeled hinge peptide (18) . Preparation of Samples for Electron Microscopic Mapping. Myosin was dialyzed into 1 M NH4OAc (pH 8.0). A P-300 column of Vb = 1.2 ml in a Pasteur pipette was poured and rinsed in the same buffer. The myosin and a-hinge IgG were mixed (100 ,ug of myosin plus 45 ,ug of IgG; 100 pg of myosin plus 150 pig of IgG) and allowed to react for 15 min at 40C; the sample was loaded on the P-300 column and eluted at about 5 ml/hr. Samples for electron microscopy were prepared for electron microscopy as described (19, 20 (24) with modifications described below to reduce the influence ofrigor-like heads. To prepare for the sliding actin motility assay, cardiac myosin (4.7 mg/ml) in 0.5 M KCl, 0.01 M imidazole (pH 7.0), and 1 mM dithiothreitol was made 3 mM in MgCl2/2 mM ATP and 10 p.M in phalloidin. To this, 0.4 mg of F-actin per ml was added immediately before centrifugation at 30 psi (1 psi = 6.89 kPa) in a Beckman Airfuge for 15 min. The supernatant was removed and used directly in the motility assay.
Following the above procedure, myosin was diluted to 0.2 mg/ml with 0.5 M NaCl, 10 mM Mops (pH 7.0), O.1 mM EGTA, and 1 mM dithiothreitol and applied to the flow cell. Under these conditions the myosin binds as monomers to the nitrocellulose surface. After washing with a buffer containing 0.5 mg of bovine serum albumin per ml, the flow cell was washed with motility buffer [20 mM KCl, 10 mM Mops (pH 7.2), 5 mM MgCl2, 0.1 mM EGTA, and 2 mM dithiothreitol] containing 0.2 mg ofthe appropriate IgG per ml and incubated for 30 min at room temperature or 3 hr at 4°C. The antibody solution was then washed out with motility buffer and this was replaced with fresh motility buffer containing 20 ,uM F-actin labeled with phalloidin that had been incubated in a sonicating water bath for 10 min (this treatment also tends to reduce the effect of rigor-like myosin heads). After 1-2 min of incubation this solution was replaced with 10 nM rhodamine phalloidin-labeled F-actin in motility buffer and then washed with motility buffer containing 1 mM ATP to start the reaction. Fields of actin filaments were videotaped for a duration of 3-5 min. ATPase assays were performed as described (13, 25) in a 5-ml assay mixture containing 2.5 mM ATP, 3.25 mM MgCl2, 20 mM KCl, and either 0.1 niM CaCl2 or 2 mM EGTA at 25°C or 30°C and pH 7.5. Control assays were performed using S1 and actin. S1 concentration in the reaction mixture was 0.05 mg/ml and that of actin was 0.27 mg/ml. The molar ratio of antibody to S1 was varied from 1:3 to 1:1.
RESULTS
Specificity of the Antibody to the Cardiac Myosin Hinge Region. The effective crossreactivity of the various myosins with the antibody against hinge peptide was evaluated by competitive inhibition RIAs. Cardiac myosin from normal and dilated cardiomyopathic human hearts as well as from dog and rat heart inhibited the binding of purified hinge peptide to surface-bound anti-hinge IgG (Fig. 1) . Turkey gizzard smooth and rabbit skeletal muscle myosins were relatively inefficient as inhibitors. Quantitative dot blot analysis confirmed the specificity of the anti-hinge antibody for cardiac myosin (data not shown). The antibody had no crossreactivity with bovine serum albumin, which was used to couple the hinge peptide for preparation of antibody. SDS/PAGE (Fig. 2D, lanes 1-3) and Western blot analysis also showed no reaction with either cardiac S1 (Fig. 2D, lane  5) or bovine aortic smooth muscle myosin (Fig. 2D, lane 6 ), but the antibody did react with the whole cardiac myosin (Fig. 2D, lane 4) .
Macromolecular Electron Microscopy Lcal the Hinge Peptide Antigenic Site on Human Cardiac Myosin. Platinumshadowed particles clearly indicate an extra globular structure on the myosin tail ( Fig. 2A) corresponding to the anti-hinge IgG. The last frame in this series (on the right) shows a pair of myosin molecules crosslinked by the antibody. Parameters A and B (Fig. 2B) are the distances from the S1/S2junction or from the distal tip ofthe myosin head to the center of the globular IgG, respectively. The distance from the S1/S2 junction (parameter A) was 55 nm (Fig. 2C) , and that from the tip of the myosin head to the IgG (parameter B) was 72 nm, which agrees well with expected distance of the hinge from the S1/S2 junction, after allowing for the dimensions of the IgG marker.
Effect of Antibody on in Vitro Motlity Measurements and ATPase Activity. The myofibrillar ATPase activity performed in the presence and absence of anti-hinge peptide antibody as a function of calcium did not change significantly. In control 100. assays, myofibrils responded to calcium as expected: the activity in the presence of calcium was 0.12 ,umol of Pi min' mg-1, and in its absence it was reduced to 0.034 ;kmol of Pi min'*mg-1 (Table 1 ). The corresponding activities in the presence of the antibody were 0.135 and 0.037 11mol of Pi min1-mg-1 (Table 1) . Also, the antibody had no effect on the actin-activated ATPase of S1 in the presence of a 15-fold molar excess of actin. The specific activity in the absence of antibody was 0.27 Amol of Pi-mink1mg-1 and 0.32 and 0.34 pmol of Pi-min-1mg-1 in the presence of affinitypurified antibody at antibody-to-Si molar ratios of 1:2 and 1:1, respectively. When DEAE-purified antibody was used at molar ratios of 1:3 and 1:1 the corresponding activities were 0.20 and 0.23 kkmol of P,-min-1mg-1. Thus, the actinactivated ATPase activity remained essentially constant at all concentrations of the antibody used, indicating that it did not interfere with the active site of myosin.
The results obtained from motility measurements were drastically different. The measured rate of movement of control myosin was 0.510 ± 0.042 ,um-s-1. This velocity was reduced to 0.247 ± 0.021 Am s-1 in the presence of DEAEpurified antibody and it was zero in the presence of the affinity-purified antibody. The rate did not significantly change when nonimmune IgG was included in the assay mixture ( Table 1 ). The rate of movement of actin filaments on tAssayed for motility after 30 min of incubation with the antibody. tAssayed in the presence of antibody further purified on an affinity column. §Affinity-purified antibody was mixed with myofibrils (26) at a molar ratio of either 1:1 or 1.5:1 with respect to myosin, considering a 50%0 myosin content in myofibrils (27) . The mixture was incubated overnight on ice to allow equilibration and binding of antibody to myosin. The KCI concentration during incubation was adjusted to 0.6 M to allow interaction of the antibody with myofibrillar myosin. Either nonimmune IgG or phosphate-buffered saline alone was included in separate assays to determine the specificity of the antibody for the observed effect. S1 used as control was also not influenced in the presence of the antibody: the rates were 0.375 ± 0.04 and 0.391 ± 0.01 ,um-s 1 (Table 1) in the presence and absence ofthe antibody, respectively, suggesting that the observed effect was specifically due to the binding of the antibody in the hinge region of the monomeric myosin used in these assays.
Measurements of Sarcomere Shortening. The response of the isolated myocytes to calcium iontophoresis was blocked within 30 min after addition of anti-hinge antibody (15 mg/ml, DEAE-purified) and 0.65 mg/ml (affinity-purified) to achieve a final concentration of 0.1 mg/ml. For example, all 13 control cells tested responded to iontophoresis, whereas only 1 in 14 and 0 in 4 responded after addition of DEAE-or affinity-purified antibody, respectively. However, shortening could still be induced by direct addition of large amounts of calcium (=50 ,ul of 0.1 M CaCl2) to the cells suppressed with either anti-hinge antibody (righthand panels in Fig. 3 B  and C) . The effect of antibody was reproduced in another heart where the cells were uniformly preexposed to 0.1 mg of antibody per ml overnight, at a calculated concentration of 25:1 antibody to total cellular myosin by weight in each aliquot. All 11 control cells responded by an average shortening of 0.39 ± 0.12 gm (mean ± SD); all 9 cells tested that were incubated in DEAE-purified antibody responded but shortened less, 0.18 ± 0.12 ,m, whereas only 2 in 6 cells tested with affinity-purified antibody shortened (0.07 ± 0.16 ,um), despite use of currents twice as long as used in the control cells. Observations in three additional hearts indicated that the peak velocity of shortening was reduced after 2-3 hr of exposure to antibody. For control the peak velocity was 1.86 ± 0.78 ,um s-1 (mean ± SD, 13 cells); peak velocity was 1.44 ± 1.20 ,ums-1 (18 cells), 0.62 ± 0.58 ,um s-1 (16 cells), and 0.48 ± 0.23 ,ums-s (7 cells) for cells treated with 1.3 mg of DEAE-purified antibody per ml and 25 and 50 mg of affinity-purified antibody per ml, respectively. Thus, the antibody influenced the dynamics of shortening in the calcium-regulated contractile lattice. Contraction was studied when activation was steady, uniform, and controlled to rule out an unspecified viscous hindrance to motion. Fig. 4 illustrates the effect of overnight incubation with antibody upon the relationship between free calcium concentration and sarcomere length. To eliminate any potential effect of nonspecific protein binding and of added protein on the calcium ion equilibria (28, 29) , control measurements were made in the presence ofnonimmune IgG. Linear regression of the means indicated that calciumactivated steady shortening was reduced o50% by the antihinge antibody (Fig. 4A) , although in one instance (see Fig.   4A , [Ca2I] = 400 nM) the affinity-purified anti-hinge antibody almost completely repressed shortening. The antibody appeared to depress systematically steady sarcomere shortening when paired to controls in IgG under matched conditions of study (Fig. 4B) . These parametric relations indicated that the slope of the dependence of length of sarcomeres exposed to anti-hinge antibody relative to those exposed to IgG (0.58, R2 = 0.99) was equivalent to that of anti-hinge antibody relative to control cells (0.60, R2 = 0.77).
A paired comparison of the effect of 0.15 mg of antibody per ml on cells isolated from the same hearts indicated that depression of shortening by affinity-purified antibody was always greater than that by DEAE-purified antibody. The greater impairment of steady shortening by the affinitypurified anti-hinge antibody parallels the corresponding differences observed in in vitro motility assays.
DISCUSSION
The actomyosin interaction constitutes the molecular mechanism of motility, regulation of contractility, and power generation in muscle. Since the S1 head of myosin contains all of the actin binding and enzymatic activities, it is likely to be involved in such a power stroke. At the same time, involvement of the S2 region in contraction has also been proposed, based on physical-chemical (5, 30) and immuno- (32) .
In vitro motility assays, however, have shown that the S2 region is not obligatory for movement. The myosin head alone, S1, is capable either of moving along actin filaments in the Nitella-based assay, of inducing actin filaments to move on Si-coated surfaces (1-3) , or of generating force (4) . However, the rate of movement induced by S1 in motility Proc. Natl. Acad Sci. USA 88 (1991) assays is less than that induced by myosin or heavy meromyosin. It is not known whether this is due to improper binding of the S1 head to the surface or to a lack of an S2-hinge region. An explanation of shortening in terms of an obligatory role of simple, vectorial change in the length of S2 appears to be ruled out by the observation that the direction of myofilament sliding is determined by actin polarity rather than the orientation of myosin in native thick filaments (33) . However, the slower velocity observed when actin filaments move away from the center of the thick filaments suggests that a properly oriented S2 region may be required for a maximal effect.
The biochemical and physiological data reported here provide a direct demonstration of the effect of the hinge on contraction by using a 20-amino acid residue peptide as antigen (15) rather than the whole S2 (10) . In general, these observations parallel those made using anti-S2, which induced a marked decrease in force generation (10) and shortening (11) in ATP-activated skeletal muscle. The 50% reduction in the extent of shortening of cardiac myocytes as opposed to the total inhibition of in vitro motility may be due to limits to diffusion of the antibody or heterogeneity of myosin-antibody binding in the myocytes.
The results of our motility assays allow a more direct evaluation of the effect of antibody on cardiac myosin hinge. Affinity-purified anti-hinge peptide antibody stopped movement completely while not inhibiting the MgATPase activity. Anti-LC1 antibody, on the other hand, repressed movement, but this could be due to inhibition of ATP hydrolysis, which was suppressed by the antibody in cardiac myofibrils (S.S.M., unpublished data).' Thus, the possibility of direct steric interference by the anti-hinge antibody is not likely because the binding site of the antibody is too far from the head/tail junction (55 nm) to obstruct S1 function directly. The fact that this occurs with myosin bound to the nitrocellulose-coated surface as monomers eliminates the possibility that the antibody acted by disrupting the normal packing order of myosin in filaments.
Mobility conferred by the S2 has been previously thought to be necessary to overcome the geometrical constraints to crossbridge attachment (31) . However, the antibody to the hinge region used in these studies suppresses motility and contractility without impairing the ability of myosin to hydrolyze ATP. Thus, under conditions where geometric constraints and tension generation are minimal, the influence of the hinge extends also to the power stroke and/or subsequent steps in the crossbridge cycle.
